$241 Million is the total value of Tavio Capital LLC's 15 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 38.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANTM | Sell | ANTHEM INC | $46,952,000 | -5.0% | 178,776 | -0.9% | 19.50% | +1.2% |
| HCA | New | HCA HEALTHCARE INC | $27,377,000 | – | 219,983 | +100.0% | 11.37% | – |
| WCG | New | WELLCARE HEALTH PLANS INC | $26,994,000 | – | 114,337 | +100.0% | 11.21% | – |
| ZBH | Buy | ZIMMER BIOMET HLDGS INC | $26,875,000 | -14.4% | 259,115 | +8.6% | 11.16% | -8.8% |
| MOH | Buy | MOLINA HEALTHCARE INC | $25,605,000 | +13.8% | 220,319 | +45.6% | 10.64% | +21.1% |
| UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $23,131,000 | +318.1% | 198,447 | +358.5% | 9.61% | +345.2% |
| LH | Buy | LABORATORY CORP AMER HLDGS | $16,045,000 | +215.2% | 126,977 | +333.2% | 6.66% | +235.5% |
| CVS | Sell | CVS HEALTH CORP | $11,198,000 | -54.9% | 170,912 | -45.8% | 4.65% | -52.0% |
| ABC | Sell | AMERISOURCEBERGEN CORP | $8,682,000 | -46.1% | 116,687 | -33.2% | 3.61% | -42.6% |
| HRTX | HERON THERAPEUTICS INC | $7,983,000 | -18.0% | 307,737 | 0.0% | 3.32% | -12.7% | |
| MEDP | Buy | MEDPACE HLDGS INC | $6,716,000 | +29.4% | 126,887 | +46.4% | 2.79% | +37.8% |
| ZGNX | Sell | ZOGENIX INC | $3,964,000 | -33.5% | 108,734 | -9.5% | 1.65% | -29.2% |
| PDCO | Sell | PATTERSON COMPANIES INC | $3,539,000 | -33.5% | 180,021 | -17.3% | 1.47% | -29.2% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $3,408,000 | -30.0% | 355,785 | -11.7% | 1.42% | -25.5% |
| RTRX | Sell | RETROPHIN INC | $2,285,000 | -72.9% | 100,985 | -65.6% | 0.95% | -71.2% |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -24,671 | -100.0% | -0.37% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -79,856 | -100.0% | -4.33% | – |
| HUM | Exit | HUMANA INC | $0 | – | -34,062 | -100.0% | -4.50% | – |
| CELG | Exit | CELGENE CORP | $0 | – | -182,027 | -100.0% | -6.35% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -152,840 | -100.0% | -8.63% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MOLINA HEALTHCARE INC | 13 | Q2 2020 | 29.6% |
| CENTENE CORP DEL | 11 | Q2 2020 | 19.1% |
| ANTHEM INC | 10 | Q2 2019 | 22.5% |
| BOSTON SCIENTIFIC CORP | 9 | Q4 2019 | 20.9% |
| RETROPHIN INC | 9 | Q1 2019 | 3.4% |
| ZIMMER BIOMET HOLDINGS INC | 8 | Q2 2020 | 20.6% |
| HUMANA INC | 8 | Q4 2019 | 37.8% |
| UNIVERSAL HLTH SVCS INC | 8 | Q1 2019 | 14.7% |
| HCA HEALTHCARE INC | 8 | Q1 2020 | 12.3% |
| MCKESSON CORP | 7 | Q2 2020 | 23.1% |
View Tavio Capital LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2020-10-01 |
| 13F-HR | 2020-08-13 |
| 13F-HR | 2020-05-14 |
| 13F-HR | 2020-02-13 |
| 13F-HR | 2019-11-13 |
| 13F-HR | 2019-08-13 |
| 13F-HR | 2019-05-14 |
| 13F-HR | 2019-02-14 |
| 13F-HR | 2018-11-13 |
| 13F-HR | 2018-08-13 |
View Tavio Capital LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.